# inDividual, Targeted thrombosIS Prophylaxis Versus the Standard One Size Fits All Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

Study · id `cardio:ct-nct06581965` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06581965](<https://clinicaltrials.gov/study/NCT06581965>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06581965

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 10078 participants.

## Technical summary

Registry record NCT06581965. Randomized; no masking; primary purpose prevention. Start 2024-11-11 (actual); primary completion 2030-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 10078 participants (planned count; ClinicalTrials.gov record NCT06581965, source copy `cardio:ctgov-nct06581965-2026-09-08`, retrieved 2026-10-31)
- Started: 2024-11-11 (actual) (ClinicalTrials.gov record NCT06581965, source copy `cardio:ctgov-nct06581965-2026-09-08`, retrieved 2026-10-31)
- Primary completion: 2030-05-01 (anticipated) (ClinicalTrials.gov record NCT06581965, source copy `cardio:ctgov-nct06581965-2026-09-08`, retrieved 2026-10-31)
- Completion: 2031-02-01 (anticipated) (ClinicalTrials.gov record NCT06581965, source copy `cardio:ctgov-nct06581965-2026-09-08`, retrieved 2026-10-31)
- Countries: Netherlands (ClinicalTrials.gov record NCT06581965, source copy `cardio:ctgov-nct06581965-2026-09-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06581965-2026-09-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
- Acronym: DISTINCT
- Condition: Venous Thromboembolism
- Condition: Venous Thromboses
- Condition: Pulmonary Embolism
- Condition: Deep Vein Thrombosis
- Intervention (Other): Short duration prophylaxis
- Intervention (Other): Higher intensity and longer duration prophylaxis
- Intervention (Other): Control
- Lead sponsor: Leiden University Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Leiden University Medical Center (`cardio:org-leiden-university-medical-center`)

## Provenance

Content hash: e843efecae8d1484232beb7ff207884cfd445058f21b6c6d917e93e637737338
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
